{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T04:42:54Z","timestamp":1792816974657,"version":"4.5.0"},"reference-count":236,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.pharmthera.2011.11.008","type":"journal-article","created":{"date-parts":[[2011,12,6]],"date-time":"2011-12-06T19:00:40Z","timestamp":1323198040000},"page":"257-279","source":"Crossref","is-referenced-by-count":88,"title":["Matrix metalloproteinases as therapeutic targets in protozoan parasitic infections"],"prefix":"10.1016","volume":"133","author":[{"given":"Nathalie","family":"Geurts","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghislain","family":"Opdenakker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe E.","family":"Van den Steen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2011.11.008_bb0005","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S1471-4922(02)02353-X","article-title":"Breaking down the blood\u2013brain barrier: signaling a path to cerebral malaria?","volume":"18","author":"Adams","year":"2002","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0010","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1084\/jem.20051342","article-title":"Dystroglycan is selectively cleaved at the parenchymal basement membrane at sites of leukocyte extravasation in experimental autoimmune encephalomyelitis","volume":"203","author":"Agrawal","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0015","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.imlet.2005.01.009","article-title":"T helper (h)1\/Th2 and leishmania: paradox rather than paradigm","volume":"99","author":"Alexander","year":"2005","journal-title":"Immunol Lett"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0020","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1365-2249.2008.03761.x","article-title":"Evidence for involvement of TNFR1 and TIMPs in pathogenesis of post-kala-azar dermal leishmaniasis","volume":"154","author":"Ansari","year":"2008","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0025","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1080\/00034989760879","article-title":"Malarial pigment (haemozoin): a very active \u2018inert\u2019 substance","volume":"91","author":"Arese","year":"1997","journal-title":"Ann Trop Med Parasitol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0030","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1046\/j.1365-2249.2003.02174.x","article-title":"The war between the malaria parasite and the immune system: immunity, immunoregulation and immunopathology","volume":"133","author":"Artavanis-Tsakonas","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0035","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1242\/jcs.00063","article-title":"Metalloproteinase inhibitors: biological actions and therapeutic opportunities","volume":"115","author":"Baker","year":"2002","journal-title":"J Cell Sci"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0040","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.pt.2008.08.008","article-title":"Recent insights into humoral and cellular immune responses against malaria","volume":"24","author":"Beeson","year":"2008","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0045","doi-asserted-by":"crossref","first-page":"3592","DOI":"10.2174\/138161209789271852","article-title":"Intra- and interdomain flexibility in matrix metalloproteinases: functional aspects and drug design","volume":"15","author":"Bertini","year":"2009","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0050","doi-asserted-by":"crossref","first-page":"12821","DOI":"10.1074\/jbc.M809627200","article-title":"Interdomain flexibility in full-length matrix metalloproteinase-1 (MMP-1)","volume":"284","author":"Bertini","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0055","doi-asserted-by":"crossref","first-page":"21779","DOI":"10.1074\/jbc.M709966200","article-title":"MMP-12 catalytic domain recognizes triple helical peptide models of collagen V with exosites and high activity","volume":"283","author":"Bhaskaran","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0060","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/385729a0","article-title":"A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells","volume":"385","author":"Black","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0065","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1002\/eji.200940115","article-title":"Human mucosal leishmaniasis: neutrophils infiltrate areas of tissue damage that express high levels of Th17-related cytokines","volume":"40","author":"Boaventura","year":"2010","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0070","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0014-5793(98)01034-5","article-title":"Synergistic upregulation of metalloproteinase-9 by growth factors and inflammatory cytokines: an absolute requirement for transcription factor NF-kappa B","volume":"435","author":"Bond","year":"1998","journal-title":"FEBS Lett"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0075","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1111\/j.1582-4934.2010.01007.x","article-title":"Chagas' disease: an update on immune mechanisms and therapeutic strategies","volume":"14","author":"Boscardin","year":"2010","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0080","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.bbamcr.2010.01.003","article-title":"The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity","volume":"1803","author":"Brew","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0085","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1182\/blood-2009-07-235150","article-title":"Rapid activation of endothelial cells enables plasmodium falciparum adhesion to platelet-decorated von Willebrand factor strings","volume":"115","author":"Bridges","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0100","doi-asserted-by":"crossref","first-page":"6799","DOI":"10.1021\/ja001461n","article-title":"Potent and selective mechanism-based inhibition of gelatinases","volume":"122","author":"Brown","year":"2000","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0095","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1212\/WNL.55.1.104","article-title":"Blood\u2013brain barrier function in cerebral malaria and CNS infections in Vietnam","volume":"55","author":"Brown","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0090","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1046\/j.1365-2990.1999.00188.x","article-title":"Evidence of blood\u2013brain barrier dysfunction in human cerebral malaria","volume":"25","author":"Brown","year":"1999","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0105","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1093\/brain\/awf133","article-title":"Targeting leukocyte MMPs and transmigration: minocycline as a potential therapy for multiple sclerosis","volume":"125","author":"Brundula","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0110","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.bbrc.2007.05.089","article-title":"Reduced secretion and expression of gelatinase profile in Toxoplasma gondii-infected human monocytic cells","volume":"359","author":"Buache","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0115","doi-asserted-by":"crossref","first-page":"529","DOI":"10.2741\/1817","article-title":"Matrix metalloproteinases: role in arthritis","volume":"11","author":"Burrage","year":"2006","journal-title":"Front Biosci"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0120","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3109\/10409238.2010.501783","article-title":"Intracellular substrate cleavage: a novel dimension in the biochemistry, biology and pathology of matrix metalloproteinases","volume":"45","author":"Cauwe","year":"2010","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0125","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/10409230701340019","article-title":"The biochemical, biological, and pathological kaleidoscope of cell surface substrates processed by matrix metalloproteinases","volume":"42","author":"Cauwe","year":"2007","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2011.04.006","article-title":"The prospects of minocycline in multiple sclerosis","volume":"235","author":"Chen","year":"2011","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0135","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1161\/CIRCULATIONAHA.107.733238","article-title":"Ablation of matrix metalloproteinase-9 increases severity of viral myocarditis in mice","volume":"117","author":"Cheung","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0140","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1179\/136485911X12987676649502","article-title":"Elevated concentrations of matrix metalloproteinase-12 and elastin degradation products in the sera of pregnant women infected with Toxoplasma gondii","volume":"105","author":"Chou","year":"2011","journal-title":"Ann Trop Med Parasitol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0145","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1038\/sj.emboj.7600318","article-title":"Collagenase unwinds triple-helical collagen prior to peptide bond hydrolysis","volume":"23","author":"Chung","year":"2004","journal-title":"EMBO J"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/AN20100027","article-title":"T cell production of matrix metalloproteases and inhibition of parasite clearance by TIMP-1 during chronic toxoplasma infection in the brain","volume":"3","author":"Clark","year":"2010","journal-title":"ASN Neuro"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0150","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.biocel.2007.12.006","article-title":"The regulation of matrix metalloproteinases and their inhibitors","volume":"40","author":"Clark","year":"2008","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0160","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2174\/1567202043480116","article-title":"Cerebral malaria \u2014 a neurovascular pathology with many riddles still to be solved","volume":"1","author":"Coltel","year":"2004","journal-title":"Curr Neurovasc Res"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0165","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.ijpara.2006.02.005","article-title":"Cerebral malaria: role of microparticles and platelets in alterations of the blood\u2013brain barrier","volume":"36","author":"Combes","year":"2006","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0170","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/1531-8249(199909)46:3<391::AID-ANA15>3.0.CO;2-0","article-title":"Cerebrospinal fluid levels of MMP-2, 7, and 9 are elevated in association with human immunodeficiency virus dementia","volume":"46","author":"Conant","year":"1999","journal-title":"Ann Neurol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0175","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.actatropica.2008.03.006","article-title":"In vitro evidence for metallopeptidase participation in hepatocyte damage induced by leishmania chagasi-infected macrophages","volume":"106","author":"Costa","year":"2008","journal-title":"Acta Trop"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0180","doi-asserted-by":"crossref","first-page":"4168","DOI":"10.1172\/JCI44423","article-title":"Advances and challenges in malaria vaccine development","volume":"120","author":"Crompton","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0185","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/08916930500485002","article-title":"Induction of cardiac autoimmunity in Chagas heart disease: a case for molecular mimicry","volume":"39","author":"Cunha-Neto","year":"2006","journal-title":"Autoimmunity"},{"issue":"Suppl. 1","key":"10.1016\/j.pharmthera.2011.11.008_bb0190","first-page":"27","article-title":"Mechanisms underlying trypanosome-elicited immunosuppression","volume":"72","author":"Darji","year":"1992","journal-title":"Ann Soc Belg Med Trop"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0195","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1529-8019.2009.01272.x","article-title":"Cutaneous and mucocutaneous leishmaniasis","volume":"22","author":"David","year":"2009","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0200","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0166-6851(94)90172-4","article-title":"The serum resistance-associated (SRA) gene of Trypanosoma brucei rhodesiense encodes a variant surface glycoprotein-like protein","volume":"68","author":"De Greef","year":"1994","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0205","doi-asserted-by":"crossref","first-page":"492","DOI":"10.4269\/ajtmh.2009.80.492","article-title":"ADAMTS13 deficiency with elevated levels of ultra-large and active von Willebrand factor in P. falciparum and P. vivax malaria","volume":"80","author":"de Mast","year":"2009","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0210","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1002\/eji.200939455","article-title":"Murine visceral leishmaniasis: IgM and polyclonal B-cell activation lead to disease exacerbation","volume":"40","author":"Deak","year":"2010","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0215","first-page":"173","article-title":"Macrophages\/microglial cells in patients with cerebral malaria","volume":"13","author":"Deininger","year":"2002","journal-title":"Eur Cytokine Netw"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0220","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0165-5728(03)00250-9","article-title":"Angiogenic proteins in brains of patients who died with cerebral malaria","volume":"142","author":"Deininger","year":"2003","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0230","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/1475-2875-9-208","article-title":"Ellagitannins of the fruit rind of pomegranate (Punica granatum) antagonize in vitro the host inflammatory response mechanisms involved in the onset of malaria","volume":"9","author":"Dell'agli","year":"2010","journal-title":"Malar J"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0225","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jep.2009.06.025","article-title":"Antiplasmodial activity of Punica granatum L. fruit rind","volume":"125","author":"Dell'agli","year":"2009","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0235","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.cimid.2004.03.004","article-title":"Leishmaniasis: current situation and new perspectives","volume":"27","author":"Desjeux","year":"2004","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0240","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1086\/587943","article-title":"Matrix metalloproteinases and their tissue inhibitors (TIMPs) in Plasmodium falciparum malaria: serum levels of TIMP-1 are associated with disease severity","volume":"197","author":"Dietmann","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0245","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1749-6632.1999.tb07688.x","article-title":"Preclinical and clinical studies of MMP inhibitors in cancer","volume":"878","author":"Drummond","year":"1999","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0250","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1002\/1521-4141(200208)32:8<2163::AID-IMMU2163>3.0.CO;2-Q","article-title":"Gelatinase B deficiency protects against endotoxin shock","volume":"32","author":"Dubois","year":"2002","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0255","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0162-0134(02)00372-0","article-title":"Physico-chemical aspects of hemozoin (malaria pigment) structure and formation","volume":"91","author":"Egan","year":"2002","journal-title":"J Inorg Biochem"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0260","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1365-2249.2005.02840.x","article-title":"The paradox of matrix metalloproteinases in infectious disease","volume":"142","author":"Elkington","year":"2005","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0265","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s00018-002-8472-0","article-title":"Sleeping sickness and the brain","volume":"59","author":"Enanga","year":"2002","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0270","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s00281-009-0177-0","article-title":"The blood\u2013brain and the blood\u2013cerebrospinal fluid barriers: function and dysfunction","volume":"31","author":"Engelhardt","year":"2009","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0275","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1002\/eji.200425327","article-title":"Mini-review: transendothelial migration of leukocytes: through the front door or around the side of the house?","volume":"34","author":"Engelhardt","year":"2004","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0280","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1387\/ijdb.041811af","article-title":"Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies","volume":"48","author":"Folgueras","year":"2004","journal-title":"Int J Dev Biol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0285","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.dld.2005.02.011","article-title":"Expression of matrix metalloproteinases-2 and -9 in intestinal tissue of patients with inflammatory bowel diseases","volume":"37","author":"Gao","year":"2005","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0290","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1046\/j.1365-3024.1996.d01-28.x","article-title":"Presence of antibodies in the aqueous humour and cerebrospinal fluid during leishmania infections in dogs. Pathological features at the central nervous system","volume":"18","author":"Garcia-Alonso","year":"1996","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0295","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.4049\/jimmunol.177.6.4103","article-title":"Selective ablation of matrix metalloproteinase-2 exacerbates experimental colitis: contrasting role of gelatinases in the pathogenesis of colitis","volume":"177","author":"Garg","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0300","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1046\/j.1365-2249.1998.00468.x","article-title":"High levels of plasma IL-10 and expression of IL-10 by keratinocytes during visceral leishmaniasis predict subsequent development of post-kala-azar dermal leishmaniasis","volume":"111","author":"Gasim","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0305","doi-asserted-by":"crossref","first-page":"175","DOI":"10.4049\/jimmunol.149.1.175","article-title":"Simultaneous depletion of CD4+ and CD8+ T lymphocytes is required to reactivate chronic infection with Toxoplasma gondii","volume":"149","author":"Gazzinelli","year":"1992","journal-title":"J Immunol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0310","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/jlb.57.5.774","article-title":"Matrix metalloproteinases and processing of pro-TNF-alpha","volume":"57","author":"Gearing","year":"1995","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0315","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1021\/bi702260q","article-title":"Beta-hematin interaction with the hemopexin domain of gelatinase B\/MMP-9 provokes autocatalytic processing of the propeptide, thereby priming activation by MMP-3","volume":"47","author":"Geurts","year":"2008","journal-title":"Biochemistry"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0320","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/j.biocel.2007.10.024","article-title":"Metalloproteinases and their inhibitors: regulators of wound healing","volume":"40","author":"Gill","year":"2008","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0325","doi-asserted-by":"crossref","first-page":"4912","DOI":"10.1128\/IAI.00455-10","article-title":"Involvement of inflammatory chemokines in survival of human monocytes fed with malarial pigment","volume":"78","author":"Giribaldi","year":"2010","journal-title":"Infect Immun"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0330","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1080\/13550280802282934","article-title":"Traversal of human and animal trypanosomes across the blood\u2013brain barrier","volume":"14","author":"Grab","year":"2008","journal-title":"J Neurovirol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0335","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1038\/nm1499","article-title":"Low nitric oxide bioavailability contributes to the genesis of experimental cerebral malaria","volume":"12","author":"Gramaglia","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0340","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1086\/367960","article-title":"Platelet accumulation in brain microvessels in fatal pediatric cerebral malaria","volume":"187","author":"Grau","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0345","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1212\/WNL.0b013e31820b7600","article-title":"CNS infection, CSF matrix metalloproteinase concentrations, and clinical\/laboratory features","volume":"76","author":"Green","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0350","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1086\/429297","article-title":"Genomewide analysis of the host response to malaria in Kenyan children","volume":"191","author":"Griffiths","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0355","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.4049\/jimmunol.179.5.2748","article-title":"African trypanosomiasis: naturally occurring regulatory T cells favor trypanotolerance by limiting pathology associated with sustained type 1 inflammation","volume":"179","author":"Guilliams","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0365","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1365-3024.2009.01108.x","article-title":"The role of parasite persistence in pathogenesis of Chagas heart disease","volume":"31","author":"Gutierrez","year":"2009","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0360","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1086\/587487","article-title":"Increased activities of cardiac matrix metalloproteinases matrix metalloproteinase (MMP)-2 and MMP-9 are associated with mortality during the acute phase of experimental Trypanosoma cruzi infection","volume":"197","author":"Gutierrez","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0370","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1365-3156.2010.02642.x","article-title":"Matrix metalloproteinase-9 and intercellular adhesion molecule 1 are powerful staging markers for human African trypanosomiasis","volume":"16","author":"Hainard","year":"2011","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0375","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S1473-3099(07)70238-4","article-title":"Haemozoin: from melatonin pigment to drug target, diagnostic tool, and immune modulator","volume":"7","author":"Hanscheid","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0380","doi-asserted-by":"crossref","first-page":"6148","DOI":"10.4049\/jimmunol.1003955","article-title":"Granzyme B expression by CD8+ T cells is required for the development of experimental cerebral malaria","volume":"186","author":"Haque","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0385","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0092-8674(02)00754-7","article-title":"Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand","volume":"109","author":"Heissig","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0390","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0140-6736(98)10178-2","article-title":"Leishmaniasis","volume":"354","author":"Herwaldt","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0395","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1161\/CIRCULATIONAHA.105.591032","article-title":"Inhibition of urokinase-type plasminogen activator or matrix metalloproteinases prevents cardiac injury and dysfunction during viral myocarditis","volume":"114","author":"Heymans","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0400","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1080\/00365540600702058","article-title":"Matrix-metalloproteinases and their inhibitors are elevated in severe sepsis: prognostic value of TIMP-1 in severe sepsis","volume":"38","author":"Hoffmann","year":"2006","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0405","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ijpara.2010.12.002","article-title":"Modulation of inflammatory response and parasitism by 15-deoxy-delta(12,14) prostaglandin J(2) in Trypanosoma cruzi-infected cardiomyocytes","volume":"41","author":"Hovsepian","year":"2011","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0410","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.bcp.2005.04.047","article-title":"Targeting neutrophil collagenase\/matrix metalloproteinase-8 and gelatinase B\/matrix metalloproteinase-9 with a peptidomimetic inhibitor protects against endotoxin shock","volume":"70","author":"Hu","year":"2005","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0415","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nrd2308","article-title":"Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases","volume":"6","author":"Hu","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0425","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.ijpara.2006.02.016","article-title":"Immunopathogenesis of cerebral malaria","volume":"36","author":"Hunt","year":"2006","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0420","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S1471-4906(03)00229-1","article-title":"Cytokines: accelerators and brakes in the pathogenesis of cerebral malaria","volume":"24","author":"Hunt","year":"2003","journal-title":"Trends Immunol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0430","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.parint.2005.10.003","article-title":"Leukocyte activation by malarial pigment","volume":"55","author":"Huy","year":"2006","journal-title":"Parasitol Int"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0435","doi-asserted-by":"crossref","first-page":"5709","DOI":"10.1021\/jo050339+","article-title":"Design, synthesis, and evaluation of a mechanism-based inhibitor for gelatinase A","volume":"70","author":"Ikejiri","year":"2005","journal-title":"J Org Chem"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0440","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1067-1927.2005.00130311.x","article-title":"Activated protein C prevents inflammation yet stimulates angiogenesis to promote cutaneous wound healing","volume":"13","author":"Jackson","year":"2005","journal-title":"Wound Repair Regen"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0445","doi-asserted-by":"crossref","first-page":"e1001021","DOI":"10.1371\/journal.ppat.1001021","article-title":"Plasmodium falciparum adhesion on human brain microvascular endothelial cells involves transmigration-like cup formation and induces opening of intercellular junctions","volume":"6","author":"Jambou","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0455","doi-asserted-by":"crossref","first-page":"e6957","DOI":"10.1371\/journal.pone.0006957","article-title":"Synthetic plasmodium-like hemozoin activates the immune response: a morphology\u2013function study","volume":"4","author":"Jaramillo","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0450","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.4049\/jimmunol.172.5.3101","article-title":"Hemozoin-inducible proinflammatory events in vivo: potential role in malaria infection","volume":"172","author":"Jaramillo","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0460","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1126\/science.1184785","article-title":"That was then but this is now: malaria research in the time of an eradication agenda","volume":"328","author":"Kappe","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0465","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/nrmicro1952","article-title":"Mechanisms of microbial traversal of the blood\u2013brain barrier","volume":"6","author":"Kim","year":"2008","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0470","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1021\/pr100556z","article-title":"Active metalloproteases of the a disintegrin and metalloprotease (ADAM) family: biological function and structure","volume":"10","author":"Klein","year":"2011","journal-title":"J Proteome Res"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0475","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.2174\/138161209787846685","article-title":"Multiple roles of the extracellular matrix in inflammation","volume":"15","author":"Korpos","year":"2009","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0480","doi-asserted-by":"crossref","first-page":"755","DOI":"10.4049\/jimmunol.116.3.755","article-title":"Protective effects of specific antibodies in Trypanosoma cruzi infections","volume":"116","author":"Krettli","year":"1976","journal-title":"J Immunol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0485","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.pneurobio.2009.12.001","article-title":"African trypanosome infections of the nervous system: parasite entry and effects on sleep and synaptic functions","volume":"91","author":"Kristensson","year":"2010","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0490","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1172\/JCI118286","article-title":"IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes","volume":"96","author":"Lacraz","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0495","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.molbiopara.2011.01.009","article-title":"Toxoplasma gondii toxolysin 4 is an extensively processed putative metalloproteinase secreted from micronemes","volume":"177","author":"Laliberte","year":"2011","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0500","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nature04808","article-title":"IL-23 promotes tumour incidence and growth","volume":"442","author":"Langowski","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0505","doi-asserted-by":"crossref","first-page":"e1000349","DOI":"10.1371\/journal.ppat.1000349","article-title":"Severe plasmodium falciparum malaria is associated with circulating ultra-large von Willebrand multimers and ADAMTS13 inhibition","volume":"5","author":"Larkin","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0515","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.canlet.2009.08.029","article-title":"The activity of a designer tissue inhibitor of metalloproteinases (TIMP)-1 against native membrane type 1 matrix metalloproteinase (MT1-MMP) in a cell-based environment","volume":"290","author":"Lee","year":"2010","journal-title":"Cancer Lett"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0510","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1128\/IAI.73.1.661-665.2005","article-title":"Tissue inhibitor of metalloproteinase 1 regulates resistance to infection","volume":"73","author":"Lee","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0525","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1086\/313922","article-title":"Matrix metalloproteinase (MMP)-8 and MMP-9 in cerebrospinal fluid during bacterial meningitis: association with blood\u2013brain barrier damage and neurological sequelae","volume":"31","author":"Leppert","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0520","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/ana.410400606","article-title":"Interferon beta-1b inhibits gelatinase secretion and in vitro migration of human T cells: a possible mechanism for treatment efficacy in multiple sclerosis","volume":"40","author":"Leppert","year":"1996","journal-title":"Ann Neurol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0530","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1089\/08892220050058380","article-title":"Tissue inhibitor of metalloproteinase 3, matrix metalloproteinase 9, and neopterin in the cerebrospinal fluid: preferential presence in HTLV type I-infected neurologic patients versus healthy virus carriers","volume":"16","author":"Lezin","year":"2000","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0540","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1046\/j.1365-3024.1999.00237.x","article-title":"TNF-alpha, nitric oxide and IFN-gamma are all critical for development of necrosis in the small intestine and early mortality in genetically susceptible mice infected perorally with Toxoplasma gondii","volume":"21","author":"Liesenfeld","year":"1999","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0535","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1084\/jem.184.2.597","article-title":"Association of CD4+ T cell-dependent, interferon-gamma-mediated necrosis of the small intestine with genetic susceptibility of mice to peroral infection with Toxoplasma gondii","volume":"184","author":"Liesenfeld","year":"1996","journal-title":"J Exp Med"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0545","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1160\/TH09-04-0223","article-title":"Severe malaria is associated with a deficiency of von Willebrand factor cleaving protease, ADAMTS13","volume":"103","author":"L\u00f6wenberg","year":"2010","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0550","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.vetimm.2010.03.024","article-title":"Differential alterations in the activity of matrix metalloproteinases within the nervous tissue of dogs in distinct manifestations of visceral leishmaniasis","volume":"136","author":"Machado","year":"2010","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0555","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1177\/039463200702000302","article-title":"Immunopathology of leishmaniasis: an update","volume":"20","author":"Mansueto","year":"2007","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0560","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/j.1365-3024.2011.01285.x","article-title":"Levels of matrix metalloproteinase-2 and -9 in the cerebrospinal fluid of dogs with visceral leishmaniasis","volume":"33","author":"Marangoni","year":"2011","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0565","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1365-2249.2010.04285.x","article-title":"Therapeutic failure in American cutaneous leishmaniasis is associated with gelatinase activity and cytokine expression","volume":"163","author":"Maretti-Mira","year":"2011","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0570","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.bbagen.2006.10.012","article-title":"A monoclonal antibody inhibits gelatinase B\/MMP-9 by selective binding to part of the catalytic domain and not to the fibronectin or zinc binding domains","volume":"1770","author":"Martens","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0575","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1172\/JCI22104","article-title":"Cerebral vessel laminins and IFN-gamma define Trypanosoma brucei brucei penetration of the blood\u2013brain barrier","volume":"114","author":"Masocha","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0580","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1128\/AAC.50.5.1798-1804.2006","article-title":"Minocycline impedes African trypanosome invasion of the brain in a murine model","volume":"50","author":"Masocha","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0585","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.molmed.2007.09.001","article-title":"Matrix metalloproteinase dysregulation in HIV infection: implications for therapeutic strategies","volume":"13","author":"Mastroianni","year":"2007","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0590","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/0169-4758(94)90159-7","article-title":"Cycles within cycles: the interplay between differentiation and cell division in Trypanosoma brucei","volume":"10","author":"Matthews","year":"1994","journal-title":"Parasitol Today"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0595","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1128\/IAI.71.2.1008-1010.2003","article-title":"Migration through the extracellular matrix by the parasitic protozoan leishmania is enhanced by surface metalloprotease Gp63","volume":"71","author":"McGwire","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0600","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1126\/science.289.5482.1202","article-title":"Inflammation dampened by gelatinase A cleavage of Monocyte chemoattractant protein-3","volume":"289","author":"McQuibban","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0610","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/S0002-9440(10)64973-5","article-title":"Reactive changes of retinal microglia during fatal murine cerebral malaria: effects of dexamethasone and experimental permeabilization of the blood\u2013brain barrier","volume":"156","author":"Medana","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0605","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.ijpara.2006.02.004","article-title":"Human cerebral malaria and the blood\u2013brain barrier","volume":"36","author":"Medana","year":"2006","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0620","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.tvjl.2010.03.017","article-title":"High levels of serum matrix metalloproteinases in dogs with natural visceral leishmaniosis: a preliminary report","volume":"188","author":"Melo","year":"2011","journal-title":"Vet J"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0615","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.vetpar.2009.03.002","article-title":"Leukocyte entry into the CNS of leishmania chagasi naturally infected dogs","volume":"162","author":"Melo","year":"2009","journal-title":"Vet Parasitol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0625","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/ana.20111","article-title":"Minocycline reduces gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis","volume":"55","author":"Metz","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0630","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nrneurol.2009.23","article-title":"Diagnosis and management of the neurological complications of falciparum malaria","volume":"5","author":"Mishra","year":"2009","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0635","doi-asserted-by":"crossref","first-page":"9462","DOI":"10.1021\/bi0260132","article-title":"The tumor necrosis factor-alpha converting enzyme (TACE): a unique metalloproteinase with highly defined substrate selectivity","volume":"41","author":"Mohan","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0640","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/S0140-6736(04)16412-X","article-title":"Toxoplasmosis","volume":"363","author":"Montoya","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0645","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/385733a0","article-title":"Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha","volume":"385","author":"Moss","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0650","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.ceb.2004.07.010","article-title":"Regulation of matrix biology by matrix metalloproteinases","volume":"16","author":"Mott","year":"2004","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0655","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1046\/j.0305-1846.2001.00306.x","article-title":"Trypanosoma brucei brucei crosses the blood\u2013brain barrier while tight junction proteins are preserved in a rat chronic disease model","volume":"27","author":"Mulenga","year":"2001","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0660","first-page":"R1203","article-title":"Gelatinase B modulates selective opening of the blood\u2013brain barrier during inflammation","volume":"274","author":"Mun-Bryce","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0665","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1084\/jem.20090900","article-title":"Interleukin (IL)-23 mediates Toxoplasma gondii-induced immunopathology in the gut via matrixmetalloproteinase-2 and IL-22 but independent of IL-17","volume":"206","author":"Munoz","year":"2009","journal-title":"J Exp Med"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0670","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1600-065X.2010.00992.x","article-title":"Immunology of Toxoplasma gondii","volume":"240","author":"Munoz","year":"2011","journal-title":"Immunol Rev"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0675","doi-asserted-by":"crossref","first-page":"38022","DOI":"10.1074\/jbc.M306842200","article-title":"Plasmodium falciparum falcilysin: a metalloprotease with dual specificity","volume":"278","author":"Murata","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0680","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2174\/138920108783497631","article-title":"Matrix metalloproteinase-9\/gelatinase B is a putative therapeutic target of chronic obstructive pulmonary disease and multiple sclerosis","volume":"9","author":"Muroski","year":"2008","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0690","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.cardiores.2005.12.002","article-title":"Structure and function of matrix metalloproteinases and TIMPs","volume":"69","author":"Nagase","year":"2006","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0685","doi-asserted-by":"crossref","first-page":"21491","DOI":"10.1074\/jbc.274.31.21491","article-title":"Matrix metalloproteinases","volume":"274","author":"Nagase","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0695","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.4049\/jimmunol.170.4.2221","article-title":"Perforin-dependent brain-infiltrating cytotoxic CD8+ T lymphocytes mediate experimental cerebral malaria pathogenesis","volume":"170","author":"Nitcheu","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0700","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.hepres.2003.09.002","article-title":"Reduced activity of matrix metalloproteinase-9 in Trypanosoma cruzi-infected mouse embryo hepatocyte cell","volume":"28","author":"Nogueira de Melo","year":"2004","journal-title":"Hepatol Res"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0705","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1189\/jlb.69.6.851","article-title":"Gelatinase B functions as regulator and effector in leukocyte biology","volume":"69","author":"Opdenakker","year":"2001","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0710","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S1471-4906(01)02023-3","article-title":"Gelatinase B: a tuner and amplifier of immune functions","volume":"22","author":"Opdenakker","year":"2001","journal-title":"Trends Immunol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0715","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nrc1821","article-title":"Tumour microenvironment \u2014 opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy","volume":"6","author":"Overall","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0725","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0006-2952(96)00168-2","article-title":"The gelatinase inhibitory activity of tetracyclines and chemically modified tetracycline analogues as measured by a novel microtiter assay for inhibitors","volume":"52","author":"Paemen","year":"1996","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0720","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1468-1331.1994.tb00051.x","article-title":"Evaluation of gelatinases and IL-6 in the cerebrospinal fluid of patients with optic neuritis, multiple sclerosis and other inflammatory neurological diseases","volume":"1","author":"Paemen","year":"1994","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0730","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nrm2125","article-title":"Matrix metalloproteinases and the regulation of tissue remodelling","volume":"8","author":"Page-McCaw","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0735","doi-asserted-by":"crossref","first-page":"30918","DOI":"10.1074\/jbc.M110.136903","article-title":"NMR and bioinformatics discovery of exosites that tune metalloelastase specificity for solubilized elastin and collagen triple helices","volume":"285","author":"Palmier","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0740","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/nri1418","article-title":"Matrix metalloproteinases as modulators of inflammation and innate immunity","volume":"4","author":"Parks","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0745","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.biocel.2008.12.012","article-title":"PfEMP1: an antigen that plays a key role in the pathogenicity and immune evasion of the malaria parasite plasmodium falciparum","volume":"41","author":"Pasternak","year":"2009","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0750","doi-asserted-by":"crossref","first-page":"642","DOI":"10.4269\/ajtmh.1994.51.642","article-title":"Vascular clogging, mononuclear cell margination, and enhanced vascular permeability in the pathogenesis of human cerebral malaria","volume":"51","author":"Patnaik","year":"1994","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0755","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.micinf.2005.10.002","article-title":"The variant surface glycoprotein as a tool for adaptation in African trypanosomes","volume":"8","author":"Pays","year":"2006","journal-title":"Microbes Infect"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0760","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/nrmicro1428","article-title":"The trypanolytic factor of human serum","volume":"4","author":"Pays","year":"2006","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0765","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000058846","article-title":"Malaria and the immune system in humans","volume":"80","author":"Perlmann","year":"2002","journal-title":"Chem Immunol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0770","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1080\/00034983.1994.11812911","article-title":"Blood\u2013brain barrier damage in experimental African trypanosomiasis","volume":"88","author":"Philip","year":"1994","journal-title":"Ann Trop Med Parasitol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0775","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1189\/jlb.1006629","article-title":"Hemopexin domains as multifunctional liganding modules in matrix metalloproteinases and other proteins","volume":"81","author":"Piccard","year":"2007","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0780","doi-asserted-by":"crossref","first-page":"430","DOI":"10.4269\/ajtmh.1994.51.430","article-title":"Plasmodium falciparum pigment induces monocytes to release high levels of tumor necrosis factor-alpha and interleukin-1 beta","volume":"51","author":"Pichyangkul","year":"1994","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0785","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1172\/JCI116341","article-title":"Cytokine patterns in the pathogenesis of human leishmaniasis","volume":"91","author":"Pirmez","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0790","first-page":"31","article-title":"Ultrastructural changes in the blood\u2013brain barrier of mice infected with Plasmodium berghei","volume":"60","author":"Polder","year":"1992","journal-title":"Acta Leiden"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0815","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1111\/j.1462-5822.2011.01620.x","article-title":"Natural haemozoin modulates matrix metalloproteinases and induces morphological changes in human microvascular endothelium","volume":"13","author":"Prato","year":"2011","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0810","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1111\/j.1462-5822.2010.01508.x","article-title":"Role of the NF-KappaB transcription pathway in the haemozoin- and 15-HETE-mediated activation of matrix metalloproteinase-9 in human adherent monocytes","volume":"12","author":"Prato","year":"2010","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0805","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/1475-2875-7-157","article-title":"Phagocytosis of haemozoin (malarial pigment) enhances metalloproteinase-9 activity in human adherent monocytes: role of IL-1beta and 15-HETE","volume":"7","author":"Prato","year":"2008","journal-title":"Malar J"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0795","doi-asserted-by":"crossref","first-page":"628435","DOI":"10.1155\/2011\/628435","article-title":"Matrix metalloproteinase-9 and haemozoin: wedding rings for human host and plasmodium falciparum parasite in complicated malaria","volume":"2011","author":"Prato","year":"2011","journal-title":"J Trop Med"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0800","doi-asserted-by":"crossref","first-page":"6436","DOI":"10.4049\/jimmunol.175.10.6436","article-title":"Phagocytosis of hemozoin enhances matrix metalloproteinase-9 activity and TNF-alpha production in human monocytes: role of matrix metalloproteinases in the pathogenesis of falciparum malaria","volume":"175","author":"Prato","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0820","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2174\/187153009789839219","article-title":"Immune cell entry to central nervous system\u2014current understanding and prospective therapeutic targets","volume":"9","author":"Prendergast","year":"2009","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0825","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.matbio.2007.07.001","article-title":"Control of matrix metalloproteinase catalytic activity","volume":"26","author":"Ra","year":"2007","journal-title":"Matrix Biol"},{"issue":"Suppl. 1","key":"10.1016\/j.pharmthera.2011.11.008_bb0830","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1590\/S0074-02762009000900021","article-title":"Chagas heart disease: pathophysiologic mechanisms, prognostic factors and risk stratification","volume":"104","author":"Rassi","year":"2009","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0835","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/S0140-6736(10)60061-X","article-title":"Chagas disease","volume":"375","author":"Rassi","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0840","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.vetimm.2008.10.307","article-title":"Systemic and compartmentalized immune response in canine visceral leishmaniasis","volume":"128","author":"Reis","year":"2009","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0845","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1365-3024.1992.tb00471.x","article-title":"Naturally acquired cellular and humoral immune responses to the major merozoite surface antigen (PfMSP1) of Plasmodium falciparum are associated with reduced malaria morbidity","volume":"14","author":"Riley","year":"1992","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0850","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1017\/S0031182009991806","article-title":"Trypanosomiasis and the brain","volume":"137","author":"Rodgers","year":"2010","journal-title":"Parasitology"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0855","doi-asserted-by":"crossref","first-page":"344","DOI":"10.4269\/ajtmh.2011.10-0487","article-title":"Magnetic resonance imaging to assess blood\u2013brain barrier damage in murine trypanosomiasis","volume":"84","author":"Rodgers","year":"2011","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0860","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S1474-4422(09)70016-X","article-title":"Matrix metalloproteinases and their multiple roles in neurodegenerative diseases","volume":"8","author":"Rosenberg","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0875","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1161\/01.STR.29.10.2189","article-title":"Matrix metalloproteinases and TIMPs are associated with blood\u2013brain barrier opening after reperfusion in rat brain","volume":"29","author":"Rosenberg","year":"1998","journal-title":"Stroke"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0870","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0006-8993(92)90681-X","article-title":"TIMP-2 reduces proteolytic opening of blood\u2013brain barrier by type IV collagenase","volume":"576","author":"Rosenberg","year":"1992","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0865","doi-asserted-by":"crossref","first-page":"E4","DOI":"10.3171\/foc.2007.22.5.5","article-title":"Vasogenic edema due to tight junction disruption by matrix metalloproteinases in cerebral ischemia","volume":"22","author":"Rosenberg","year":"2007","journal-title":"Neurosurg Focus"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0880","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.str.2007.07.019","article-title":"Insights into the structure and domain flexibility of full-length pro-matrix metalloproteinase-9\/gelatinase B","volume":"15","author":"Rosenblum","year":"2007","journal-title":"Structure"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0885","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cardiores.2005.12.009","article-title":"Myocardial proteases and matrix remodeling in inflammatory heart disease","volume":"69","author":"Rutschow","year":"2006","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0890","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.4049\/jimmunol.153.4.1714","article-title":"B lymphocytes of mice display an aberrant activation phenotype and are cell cycle arrested in G0\/G1A during acute infection with Trypanosoma brucei","volume":"153","author":"Sacco","year":"1994","journal-title":"J Immunol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0895","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/01.MP.0000051681.43441.82","article-title":"Overexpression of tissue inhibitor of metalloproteinases-3 in intestinal and cutaneous lesions of graft-versus-host disease","volume":"16","author":"Salmela","year":"2003","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0900","doi-asserted-by":"crossref","first-page":"4894","DOI":"10.1128\/IAI.63.12.4894-4899.1995","article-title":"Disruption of the murine interleukin-4 gene inhibits disease progression during leishmania Mexicana infection but does not increase control of Leishmania donovani infection","volume":"63","author":"Satoskar","year":"1995","journal-title":"Infect Immun"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0905","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/nri1686","article-title":"Immunological processes in malaria pathogenesis","volume":"5","author":"Schofield","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0910","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1021\/tx8002752","article-title":"Comparative analysis of gene expression changes mediated by individual constituents of hemozoin","volume":"22","author":"Schrimpe","year":"2009","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0915","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/1475-2875-8-195","article-title":"Differential gene expression mediated by 15-hydroxyeicosatetraenoic acid in LPS-stimulated RAW 264.7 cells","volume":"8","author":"Schrimpe","year":"2009","journal-title":"Malar J"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0925","first-page":"199","article-title":"15(S)-hydroxyeicosatetraenoic acid (15-HETE), a product of arachidonic acid peroxidation, is an active component of hemozoin toxicity to monocytes","volume":"41","author":"Schwarzer","year":"1999","journal-title":"Parassitologia"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0930","first-page":"143","article-title":"Hemozoin and the human monocyte\u2014a brief review of their interactions","volume":"50","author":"Schwarzer","year":"2008","journal-title":"Parassitologia"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0920","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1084\/jem.176.4.1033","article-title":"Impairment of macrophage functions after ingestion of plasmodium Falciparum-infected erythrocytes or isolated malarial pigment","volume":"176","author":"Schwarzer","year":"1992","journal-title":"J Exp Med"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0935","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1046\/j.1365-3024.1999.00254.x","article-title":"Hemozoin is a key factor in the induction of malaria-associated immunosuppression","volume":"21","author":"Scorza","year":"1999","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0940","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0304-3835(02)00699-7","article-title":"Membrane-type 1 matrix metalloproteinase: a key enzyme for tumor invasion","volume":"194","author":"Seiki","year":"2003","journal-title":"Cancer Lett"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0945","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.vetpar.2009.12.042","article-title":"Toxoplasma gondii infection positively modulates the macrophages migratory molecular complex by increasing matrix metalloproteinases, CD44 and alpha v beta 3 integrin","volume":"169","author":"Seipel","year":"2010","journal-title":"Vet Parasitol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0950","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.bbamcr.2009.04.010","article-title":"Structural and functional bases for allosteric control of MMP activities: can it pave the path for selective inhibition?","volume":"1803","author":"Sela-Passwell","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0955","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0002-9440(10)65136-X","article-title":"A quantitative analysis of the microvascular sequestration of malaria parasites in the human brain","volume":"155","author":"Silamut","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0960","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.4049\/jimmunol.173.6.4066","article-title":"Hemozoin (malarial pigment) inhibits differentiation and maturation of human monocyte-derived dendritic cells: a peroxisome proliferator-activated receptor-gamma-mediated effect","volume":"173","author":"Skorokhod","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0965","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/oxfordjournals.bmb.a011689","article-title":"New insights into the epidemiology of malaria relevant for disease control","volume":"54","author":"Snow","year":"1998","journal-title":"Br Med Bull"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0970","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/nri2852","article-title":"The impact of the extracellular matrix on inflammation","volume":"10","author":"Sorokin","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0975","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.phrs.2010.10.005","article-title":"Collagenase-2 (MMP-8) as a point-of-care biomarker in periodontitis and cardiovascular diseases. Therapeutic response to non-antimicrobial properties of tetracyclines","volume":"63","author":"Sorsa","year":"2011","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0980","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1152\/physrev.00012.2007","article-title":"Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function","volume":"87","author":"Spinale","year":"2007","journal-title":"Physiol Rev"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0985","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/sj.icb7100011","article-title":"Balancing immunity and pathology in visceral leishmaniasis","volume":"85","author":"Stanley","year":"2007","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0990","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1146\/annurev.cellbio.17.1.463","article-title":"How matrix metalloproteinases regulate cell behavior","volume":"17","author":"Sternlicht","year":"2001","journal-title":"Annu Rev Cell Dev Biol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb0995","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1007\/s00401-001-0491-7","article-title":"Chemokines are differentially expressed by astrocytes, microglia and inflammatory leukocytes in Toxoplasma encephalitis and critically regulated by interferon-gamma","volume":"103","author":"Strack","year":"2002","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb1000","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1080\/13550280701258084","article-title":"Glial activation and matrix metalloproteinase release in cerebral malaria","volume":"13","author":"Szklarczyk","year":"2007","journal-title":"J Neurovirol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb1005","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1600-065X.2008.00675.x","article-title":"T cells and immunopathogenesis of experimental African trypanosomiasis","volume":"225","author":"Tabel","year":"2008","journal-title":"Immunol Rev"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb1010","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.coi.2007.06.003","article-title":"Immune system recognition of Trypanosoma cruzi","volume":"19","author":"Tarleton","year":"2007","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb1015","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.exppara.2010.01.028","article-title":"Regulation of immunity to Plasmodium: implications from mouse models for blood stage malaria vaccine design","volume":"126","author":"Taylor-Robinson","year":"2010","journal-title":"Exp Parasitol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb1020","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S1471-4922(02)02283-3","article-title":"Chemokines, inflammation and Trypanosoma cruzi infection","volume":"18","author":"Teixeira","year":"2002","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb1025","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.2174\/092986708784567680","article-title":"Progress in the development of matrix metalloproteinase inhibitors","volume":"15","author":"Tu","year":"2008","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb1030","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.1750-3639.1997.tb01075.x","article-title":"Cerebral malaria","volume":"7","author":"Turner","year":"1997","journal-title":"Brain Pathol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb1035","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1749-6632.1994.tb24731.x","article-title":"Doxycycline and chemically modified tetracyclines inhibit gelatinase a (MMP-2) gene expression in human skin keratinocytes","volume":"732","author":"Uitto","year":"1994","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb1040","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1182\/blood.V96.8.2673","article-title":"Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-alpha and leaves RANTES and MCP-2 intact","volume":"96","author":"Van den Steen","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb1045","doi-asserted-by":"crossref","first-page":"18626","DOI":"10.1074\/jbc.M512308200","article-title":"The hemopexin and O-glycosylated domains tune gelatinase B\/MMP-9 bioavailability via inhibition and binding to cargo receptors","volume":"281","author":"Van den Steen","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb1050","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/labinvest.3700454","article-title":"Matrix metalloproteinases, tissue inhibitors of MMPs and TACE in experimental cerebral malaria","volume":"86","author":"Van den Steen","year":"2006","journal-title":"Lab Invest"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb1055","doi-asserted-by":"crossref","first-page":"5578","DOI":"10.1073\/pnas.87.14.5578","article-title":"The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family","volume":"87","author":"Van Wart","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb1060","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.yjmcc.2009.09.013","article-title":"TIMPs and cardiac remodeling: \u2018embracing the MMP-independent-side of the family\u2019","volume":"48","author":"Vanhoutte","year":"2010","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb1065","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1128\/CMR.00047-08","article-title":"Matrix metalloproteinases as drug targets in infections caused by gram-negative bacteria and in septic shock","volume":"22","author":"Vanlaere","year":"2009","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb1070","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1590\/S0001-37652006000400004","article-title":"Immunology and immunopathology of African trypanosomiasis","volume":"78","author":"Vincendeau","year":"2006","journal-title":"An Acad Bras Cienc"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb1075","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1161\/01.RES.0000070112.80711.3D","article-title":"Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry","volume":"92","author":"Visse","year":"2003","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb1080","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1126\/science.1179663","article-title":"Tuberculous granuloma induction via interaction of a bacterial secreted protein with host epithelium","volume":"327","author":"Volkman","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb1090","doi-asserted-by":"crossref","first-page":"8978","DOI":"10.1128\/JVI.00314-08","article-title":"Matrix metalloproteinase 9 facilitates West Nile virus entry into the brain","volume":"82","author":"Wang","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb1095","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1440-1681.2010.05454.x","article-title":"Artemisinin inhibits extracellular matrix metalloproteinase inducer (EMMPRIN) and matrix metalloproteinase-9 expression via a protein kinase Cdelta\/P38\/extracellular signal-regulated kinase pathway in phorbol myristate acetate-induced THP-1 macrophages","volume":"38","author":"Wang","year":"2011","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb1085","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1161\/01.CIR.0000028818.33488.7B","article-title":"Intracellular action of matrix metalloproteinase-2 accounts for acute myocardial ischemia and reperfusion injury","volume":"106","author":"Wang","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb1100","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.ijpara.2009.02.004","article-title":"Toxoplasmosis: a history of clinical observations","volume":"39","author":"Weiss","year":"2009","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb1105","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/nrd2972","article-title":"New medicines to improve control and contribute to the eradication of malaria","volume":"8","author":"Wells","year":"2009","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb1110","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.yjmcc.2009.08.019","article-title":"Immunomodulation and matrix metalloproteinases in viral myocarditis","volume":"48","author":"Westermann","year":"2010","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb1115","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1021\/cr9804543","article-title":"Design and therapeutic application of matrix metalloproteinase inhibitors","volume":"99","author":"Whittaker","year":"1999","journal-title":"Chem Rev"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb1120","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1126\/science.286.5437.113","article-title":"Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense","volume":"286","author":"Wilson","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb1125","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1172\/JCI41911","article-title":"Trafficking of immune cells in the central nervous system","volume":"120","author":"Wilson","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb1130","unstructured":"www.who.int\/leishmaniasis\/en\/ (2011). Leishmaniasis. Accessed 25 February 2011."},{"key":"10.1016\/j.pharmthera.2011.11.008_bb1135","unstructured":"www.who.int\/mediacentre\/factsheets\/fs259\/en\/ (2010). African Trypanosomiasis (Sleeping Sickness). Accessed 16 February 2011."},{"key":"10.1016\/j.pharmthera.2011.11.008_bb1140","unstructured":"www.who.int\/mediacentre\/factsheets\/fs340\/en\/ (2010). Chagas Disease (American Trypanosomiasis). Accessed 18 February 2011."},{"key":"10.1016\/j.pharmthera.2011.11.008_bb1145","unstructured":"www.who.int\/topics\/malaria\/en\/ (2011). Malaria. Accessed 25 April 2011."},{"key":"10.1016\/j.pharmthera.2011.11.008_bb1150","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1517\/14728222.10.1.143","article-title":"Targeting matrix metalloproteases to improve cutaneous wound healing","volume":"10","author":"Xue","year":"2006","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb1155","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/nrn1807","article-title":"Metalloproteinases: mediators of pathology and regeneration in the CNS","volume":"6","author":"Yong","year":"2005","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb1160","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/35081571","article-title":"Metalloproteinases in biology and pathology of the nervous system","volume":"2","author":"Yong","year":"2001","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb1165","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jns.2006.11.021","article-title":"Elevation of matrix metalloproteinases (MMPs) in multiple sclerosis and impact of immunomodulators","volume":"259","author":"Yong","year":"2007","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb1170","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1101\/gad.14.2.163","article-title":"Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis","volume":"14","author":"Yu","year":"2000","journal-title":"Genes Dev"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb1175","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1038\/nn1127","article-title":"HIV-induced metalloproteinase processing of the chemokine stromal cell derived factor-1 causes neurodegeneration","volume":"6","author":"Zhang","year":"2003","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.pharmthera.2011.11.008_bb1180","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1161\/01.STR.0000253500.32979.d1","article-title":"Neurovascular proteases in brain injury, hemorrhage and remodeling after stroke","volume":"38","author":"Zhao","year":"2007","journal-title":"Stroke"}],"container-title":["Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725811002117?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725811002117?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,11]],"date-time":"2023-06-11T14:03:23Z","timestamp":1686492203000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725811002117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":236,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S0163725811002117"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2011.11.008","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}